Thursday, January 18, 2018 7:25:28 AM
Note...The Reserved Presentations, Some Company(s) Wants It Quiet Until Next Tuesday Morning.
http://www.worldstemcellsummit.com/sessions/engineering-next-frontier-cellular-immunotherapy-looking-beyond-cd19/
Material Threat MCM PRV Guidance
https://www.fda.gov/downloads/EmergencyPreparedness/Counterterrorism/MedicalCountermeasures/AboutMCMi/UCM592732.pdf
Last Paragraph:
"The agency (FDA) said it plans to review priority defense department products in a way that is similar to its current breakthrough designation program, which aims to speed products onto the market by relaxing certain clinical trial requirements and offering developers intensive FDA guidance.
https://www.reuters.com/article/us-johnson-johnson-zytiga/u-s-court-invalidates-jj-cancer-drug-patent-hitting-uks-btg-idUSKBN1F634X?feedType=RSS&feedName=healthNews
HC Wainwright set a $4.00 price target on Pluristem Therapeutics.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM